サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1790354

酵素DNA合成の市場規模、シェア、動向分析レポート：サービス別、最終用途別、地域別、セグメント別予測、2025年～2033年

Enzymatic DNA Synthesis Market Size, Share & Trends Analysis Report By Services (Oligonucleotide Synthesis, Gene Synthesis), By Application (Synthetic Biology, Vaccine Development), By End Use, By Region, And Segment Forecasts, 2025 - 2033

出版日
ページ情報
英文 120 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.16円
酵素DNA合成の市場規模、シェア、動向分析レポート：サービス別、最終用途別、地域別、セグメント別予測、2025年～2033年
出版日: 2025年07月29日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

酵素DNA合成市場の概要

世界の酵素DNA合成市場規模は、2024年に2億9,290万米ドルと推定され、2033年には24億4,470万米ドルに達し、2025～2033年のCAGRは26.65%で拡大すると予測されます。技術の進歩により、精密医療への需要の高まり、合成生物学の研究の増加、遺伝子研究やバイオテクノロジーへの資金提供の増加が、酵素DNA合成市場の成長を促進すると予測されています。

自動化のブレークスルーが酵素DNAアプリケーションの範囲を拡大

さらに、革新的な医薬品開発と遺伝子研究に重点を置くバイオ医薬品セグメントの拡大が、予測期間にわたって酵素DNA合成市場をさらに促進しています。酵素DNA合成は、分子製造の限界を押し広げ続けており、最近の画期的な進歩は、従来型バイオテクノロジーを超える可能性を示しています。PNASに掲載された先駆的な開発では、DNA-DISKプラットフォームが発表されており、これは酵素的一塩基DNA合成とシーケンスをデジタルマイクロフルイディクスと統合したものです。このエンド・ツー・エンドの完全自動化システムは、末端デオキシヌクレオチジルトランスフェラーゼ（TdT）を用いてDNA鎖にデジタルデータをコードし、従来型合成・配列決定ワークフローに代わる合理的でスケーラブルな代替手段を記載しています。過酷な化学品を排除し、水性環境での合成を可能にすることで、このプラットフォームは、より安全で、より速く、よりサステイナブル生産方法への世界のシフトに合致します。

その革新性は、書き込みから読み出しまでのDNAデータ保存サイクル全体を、コンパクトでデジタル制御されたセットアップ内で自動化する能力にあります。このシステムの酵素的な精度は、データを正確にエンコードするために不可欠な1塩基の付加を可能にします。この開発により、酵素的DNA合成は、特にバイオインフォマティクスやデジタルアーカイブのような高スループットと精度が要求される領域において、分散型合成モデルをサポートできる柔軟なツールとして強化されます。DNA Script、Molecular Assemblies、Ansa BIoTechnologiesなど、このセグメントの企業はすでに同様の技術的方向性を追求し、高度で用途に特化した合成プラットフォームの需要に応えています。

この進歩は、酵素合成技術の発展範囲と商業的可能性を反映しています。小型化され、持続可能で、自動化されたシステムに対する需要が高まるにつれ、DNA-DISKのような技術革新は重要な市場機会を示唆しています。DNAベースデータストレージは、その密度、寿命、環境効率の高さが評価され、フロンティア技術として注目を集めています。DNA配列を自律的に合成・処理する能力は、新たな共同研究や市場拡大の扉を開き、酵素合成を合成生物学、データサイエンス、分散型バイオ製造にまたがる次世代分子ソリューションの重要なイネーブラーとして位置づける。

合成生物学の未来を形作るスケーラブルなDNAイノベーション

酵素的DNA合成（EDS）は、従来型化学的手法に代わる革新的な手法として急速に台頭しており、長さ、忠実度、環境持続性といった長年の限界に対処しています。ホスホルアミダイト化学は数十年にわたりDNA合成を支配してきたが、累積サイクルの非効率性と高いエラー率により、300塩基を超える配列を効率的に生産するのに苦労しています。対照的に、EDSは末端デオキシヌクレオチジルトランスフェラーゼ（TdT）を用いて、穏やかな水性条件下でヌクレオチドを付加し、より長いDNA断片の高純度合成を可能にします。この技術的能力の飛躍は、ゲノミクス、遺伝子編集、合成生物学、mRNAによる医薬品開発などの先進的応用をサポートする上で極めて重要です。

商業的な観点からも、EDSへのシフトはライフサイエンスセグメント全体に新たな成長の道を開いています。長く、正確で、配列の多様なDNAコンストラクトを迅速かつ持続的に生産する能力は、高スループットの研究開発や分散型バイオ製造において競合を発揮します。このシフトの先駆者である開発企業は、ベンチトップ機器、オンデマンド合成サービス、治療、ワクチン開発、次世代バイオエンジニアリングでの使用に合わせた早期アクセスプログラムを提供することで、戦略的牽引力を獲得しています。産業では、反復サイクルの高速化、外注への依存度の低減、よりエコフレンドリー技術が優先される中、酵素DNA合成は競合情勢を再定義し、進化する合成生物学エコシステムの要としての地位を確立しつつあります。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 酵素DNA合成市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/付随市場の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 酵素DNA合成市場分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTEL分析

第4章 酵素DNA合成市場：サービス、推定・動向分析

  • サービスセグメントダッシュボード
  • 世界の酵素DNA合成市場のサービス変動分析
  • 世界の酵素DNA合成市場規模と動向分析（サービス別、2021～2033年）
  • オリゴヌクレオチド合成
  • 遺伝子合成

第5章 酵素DNA合成市場：用途別、推定・動向分析

  • 用途セグメントダッシュボード
  • 世界の酵素DNA合成市場の用途変動分析
  • 世界の酵素DNA合成市場規模と動向分析（用途別、2021～2033年）
  • 合成生物学
  • ワクチン開発
  • 遺伝子工学
  • その他

第6章 酵素DNA合成市場：最終用途別、推定・動向分析

  • 最終用途セグメントダッシュボード
  • 世界の酵素DNA合成市場の最終用途変動分析
  • 世界の酵素DNA合成市場規模と動向分析（最終用途別、2021～2033年）
  • バイオ医薬品企業
  • 学術研究機関
  • 契約研究機関

第7章 酵素DNA合成市場：サービス、用途、最終用途による地域別、推定・動向分析

  • 地域別市場ダッシュボード
  • 市場規模、予測動向分析、2021～2033年
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • チリ
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 企業/競合の分類
  • 戦略マッピング
  • 企業市況分析、2024年
  • 企業プロファイル/上場企業
    • Telesis Bio Inc.
    • Twist Bioscience Corporation
    • GenScript BIoTech Corp.
    • Evonetix
    • Ansa BIoTechnologies, Inc.
    • Camena Bio
    • Molecular Assemblies
    • DNA Script
    • Touchlight
    • Kern Systems
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global enzymatic DNA synthesis market, by region, 2021 to 2033 (USD Million)
  • Table 3 Global enzymatic DNA synthesis market, by services, 2021 to 2033 (USD Million)
  • Table 4 Global enzymatic DNA synthesis market, by application, 2021 to 2033 (USD Million)
  • Table 5 Global enzymatic DNA synthesis market, by end use, 2021 to 2033 (USD Million)
  • Table 6 North America enzymatic DNA synthesis market, by country, 2021 to 2033 (USD Million)
  • Table 7 North America enzymatic DNA synthesis market, by services, 2021 to 2033 (USD Million)
  • Table 8 North America enzymatic DNA synthesis market, by application, 2021 to 2033 (USD Million)
  • Table 9 North America enzymatic DNA synthesis market, by end use, 2021 to 2033 (USD Million)
  • Table 10 U.S. enzymatic DNA synthesis market, by services, 2021 to 2033 (USD Million)
  • Table 11 U.S. enzymatic DNA synthesis market, by application, 2021 to 2033 (USD Million)
  • Table 12 U.S. enzymatic DNA synthesis market, by end use, 2021 to 2033 (USD Million)
  • Table 13 Canada enzymatic DNA synthesis market, by services, 2021 to 2033 (USD Million)
  • Table 14 Canada enzymatic DNA synthesis market, by application, 2021 to 2033 (USD Million)
  • Table 15 Canada enzymatic DNA synthesis market, by end use, 2021 to 2033 (USD Million)
  • Table 16 Europe enzymatic DNA synthesis market, by country, 2021 to 2033 (USD Million)
  • Table 17 Europe enzymatic DNA synthesis market, by services, 2021 to 2033 (USD Million)
  • Table 18 Europe enzymatic DNA synthesis market, by application, 2021 to 2033 (USD Million)
  • Table 19 Europe enzymatic DNA synthesis market, by end use, 2021 to 2033 (USD Million)
  • Table 20 Germany enzymatic DNA synthesis market, by services, 2021 to 2033 (USD Million)
  • Table 21 Germany enzymatic DNA synthesis market, by application, 2021 to 2033 (USD Million)
  • Table 22 Germany enzymatic DNA synthesis market, by end use, 2021 to 2033 (USD Million)
  • Table 23 UK enzymatic DNA synthesis market, by services, 2021 to 2033 (USD Million)
  • Table 24 UK enzymatic DNA synthesis market, by application, 2021 to 2033 (USD Million)
  • Table 25 UK enzymatic DNA synthesis market, by end use, 2021 to 2033 (USD Million)
  • Table 26 France enzymatic DNA synthesis market, by services, 2021 to 2033 (USD Million)
  • Table 27 France enzymatic DNA synthesis market, by application, 2021 to 2033 (USD Million)
  • Table 28 France enzymatic DNA synthesis market, by end use, 2021 to 2033 (USD Million)
  • Table 29 Italy enzymatic DNA synthesis market, by services, 2021 to 2033 (USD Million)
  • Table 30 Italy enzymatic DNA synthesis market, by application, 2021 to 2033 (USD Million)
  • Table 31 Italy enzymatic DNA synthesis market, by end use, 2021 to 2033 (USD Million)
  • Table 32 Spain enzymatic DNA synthesis market, by services, 2021 to 2033 (USD Million)
  • Table 33 Spain enzymatic DNA synthesis market, by application, 2021 to 2033 (USD Million)
  • Table 34 Spain enzymatic DNA synthesis market, by end use, 2021 to 2033 (USD Million)
  • Table 35 Denmark enzymatic DNA synthesis market, by services, 2021 to 2033 (USD Million)
  • Table 36 Denmark enzymatic DNA synthesis market, by application, 2021 to 2033 (USD Million)
  • Table 37 Denmark enzymatic DNA synthesis market, by end use, 2021 to 2033 (USD Million)
  • Table 38 Sweden enzymatic DNA synthesis market, by services, 2021 to 2033 (USD Million)
  • Table 39 Sweden enzymatic DNA synthesis market, by application, 2021 to 2033 (USD Million)
  • Table 40 Sweden enzymatic DNA synthesis market, by end use, 2021 to 2033 (USD Million)
  • Table 41 Norway enzymatic DNA synthesis market, by services, 2021 to 2033 (USD Million)
  • Table 42 Norway enzymatic DNA synthesis market, by application, 2021 to 2033 (USD Million)
  • Table 43 Norway enzymatic DNA synthesis market, by end use, 2021 to 2033 (USD Million)
  • Table 44 Asia Pacific enzymatic DNA synthesis market, by country, 2021 to 2033 (USD Million)
  • Table 45 Asia Pacific enzymatic DNA synthesis market, by services, 2021 to 2033 (USD Million)
  • Table 46 Asia Pacific enzymatic DNA synthesis market, by application, 2021 to 2033 (USD Million)
  • Table 47 Asia Pacific enzymatic DNA synthesis market, by end use, 2021 to 2033 (USD Million)
  • Table 48 China enzymatic DNA synthesis market, by application, 2021 to 2033 (USD Million)
  • Table 49 China enzymatic DNA synthesis market, by services, 2021 to 2033 (USD Million)
  • Table 50 China enzymatic DNA synthesis market, by end use, 2021 to 2033 (USD Million)
  • Table 51 Japan enzymatic DNA synthesis market, by services, 2021 to 2033 (USD Million)
  • Table 52 Japan enzymatic DNA synthesis market, by application, 2021 to 2033 (USD Million)
  • Table 53 Japan enzymatic DNA synthesis market, by end use, 2021 to 2033 (USD Million)
  • Table 54 India enzymatic DNA synthesis market, by services, 2021 to 2033 (USD Million)
  • Table 55 India enzymatic DNA synthesis market, by application, 2021 to 2033 (USD Million)
  • Table 56 India enzymatic DNA synthesis market, by end use, 2021 to 2033 (USD Million)
  • Table 57 South Korea enzymatic DNA synthesis market, by services, 2021 to 2033 (USD Million)
  • Table 58 South Korea enzymatic DNA synthesis market, by application, 2021 to 2033 (USD Million)
  • Table 59 South Korea enzymatic DNA synthesis market, by end use, 2021 to 2033 (USD Million)
  • Table 60 Australia enzymatic DNA synthesis market, by services, 2021 to 2033 (USD Million)
  • Table 61 Australia enzymatic DNA synthesis market, by application, 2021 to 2033 (USD Million)
  • Table 62 Australia enzymatic DNA synthesis market, by end use, 2021 to 2033 (USD Million)
  • Table 63 Latin America enzymatic DNA synthesis market, by country, 2021 to 2033 (USD Million)
  • Table 64 Latin America enzymatic DNA synthesis market, by services, 2021 to 2033 (USD Million)
  • Table 65 Latin America enzymatic DNA synthesis market, by application, 2021 to 2033 (USD Million)
  • Table 66 Latin America enzymatic DNA synthesis market, by end use, 2021 to 2033 (USD Million)
  • Table 67 Brazil enzymatic DNA synthesis market, by services, 2021 to 2033 (USD Million)
  • Table 68 Brazil enzymatic DNA synthesis market, by application, 2021 to 2033 (USD Million)
  • Table 69 Brazil enzymatic DNA synthesis market, by end use, 2021 to 2033 (USD Million)
  • Table 70 Chile enzymatic DNA synthesis market, by services, 2021 to 2033 (USD Million)
  • Table 71 Chile enzymatic DNA synthesis market, by application, 2021 to 2033 (USD Million)
  • Table 72 Chile enzymatic DNA synthesis market, by end use, 2021 to 2033 (USD Million)
  • Table 73 MEA enzymatic DNA synthesis market, by country, 2021 to 2033 (USD Million)
  • Table 74 MEA enzymatic DNA synthesis market, by services, 2021 to 2033 (USD Million)
  • Table 75 MEA enzymatic DNA synthesis market, by application, 2021 to 2033 (USD Million)
  • Table 76 MEA enzymatic DNA synthesis market, by end use, 2021 to 2033 (USD Million)
  • Table 77 Saudi Arabia enzymatic DNA synthesis market, by services, 2021 to 2033 (USD Million)
  • Table 78 Saudi Arabia enzymatic DNA synthesis market, by application, 2021 to 2033 (USD Million)
  • Table 79 Saudi Arabia enzymatic DNA synthesis market, by end use, 2021 to 2033 (USD Million)
  • Table 80 UAE enzymatic DNA synthesis market, by services, 2021 to 2033 (USD Million)
  • Table 81 UAE enzymatic DNA synthesis market, by application, 2021 to 2033 (USD Million)
  • Table 82 UAE enzymatic DNA synthesis market, by end use, 2021 to 2033 (USD Million)
  • Table 83 Kuwait enzymatic DNA synthesis market, by services, 2021 to 2033 (USD Million)
  • Table 84 Kuwait enzymatic DNA synthesis market, by application, 2021 to 2033 (USD Million)
  • Table 85 Kuwait enzymatic DNA synthesis market, by end use, 2021 to 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Enzymatic DNA synthesis market: Market outlook
  • Fig. 5 Enzymatic DNA synthesis market: Segment outlook
  • Fig. 6 Enzymatic DNA synthesis market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Enzymatic DNA synthesis market driver impact
  • Fig. 9 Enzymatic DNA synthesis market restraint impact
  • Fig. 10 Enzymatic DNA synthesis market: Services outlook and key takeaways
  • Fig. 11 Enzymatic DNA synthesis market: Services movement analysis
  • Fig. 12 Oligonucleotide synthesis market estimates and forecast, 2021 to 2033 (USD Million)
  • Fig. 13 Gene synthesis market estimates and forecast, 2021 to 2033 (USD Million)
  • Fig. 14 Enzymatic DNA synthesis market: Application outlook and key takeaways
  • Fig. 15 Enzymatic DNA synthesis market: Application movement analysis
  • Fig. 16 Synthetic biology market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 17 Vaccine development market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 18 Genetic engineering market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 19 Others market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 20 Enzymatic DNA synthesis market: End use outlook and key takeaways
  • Fig. 21 Enzymatic DNA synthesis market: End use movement analysis
  • Fig. 22 Biopharmaceutical companies market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 23 Academic & research institutes market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 24 Contract research organizations market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 25 Global enzymatic DNA synthesis market: Regional outlook and key takeaways
  • Fig. 26 Global enzymatic DNA synthesis market: Regional movement analysis
  • Fig. 27 North America enzymatic DNA synthesis market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 28 U.S. enzymatic DNA synthesis market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 29 Canada enzymatic DNA synthesis market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 30 Europe enzymatic DNA synthesis market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 31 UK enzymatic DNA synthesis market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 32 Germany enzymatic DNA synthesis market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 33 France enzymatic DNA synthesis market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 34 Italy enzymatic DNA synthesis market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 35 Spain enzymatic DNA synthesis market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 36 Denmark enzymatic DNA synthesis market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 37 Sweden enzymatic DNA synthesis market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 38 Norway enzymatic DNA synthesis market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 39 Asia Pacific enzymatic DNA synthesis market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 40 China enzymatic DNA synthesis market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 41 Japan enzymatic DNA synthesis market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 42 India enzymatic DNA synthesis market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 43 South Korea enzymatic DNA synthesis market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 44 Australia enzymatic DNA synthesis market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 45 Latin America enzymatic DNA synthesis market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 46 Brazil enzymatic DNA synthesis market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 47 Chile enzymatic DNA synthesis market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 48 Middle East and Africa enzymatic DNA synthesis market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 49 Saudi Arabia enzymatic DNA synthesis market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 50 UAE enzymatic DNA synthesis market estimates and forecasts, 2021 to 2033 (USD Million)
  • Fig. 51 Kuwait enzymatic DNA synthesis market estimates and forecasts, 2021 to 2033 (USD Million)
目次
Product Code: GVR-4-68040-411-2

Enzymatic DNA Synthesis Market Summary

The global enzymatic DNA synthesis market size was estimated at USD 292.9 million in 2024, is projected to reach USD 2,444.7 million by 2033, expanding at a CAGR of 26.65% from 2025 to 2033. Owing to advancements in technology, rising demand for precision medicine, increased research in synthetic biology, and greater funding for genetic research and biotechnology are anticipated to drive the growth of the enzymatic DNA synthesis market.

Automation Breakthrough Expands Scope of Enzymatic DNA Applications

Moreover, the expanding biopharmaceutical sector, with its focus on innovative drug development and genetic research, is further propelling the enzymatic DNA synthesis market over the forecast period. Enzymatic DNA synthesis continues to push the boundaries of molecular manufacturing, with recent breakthroughs demonstrating its potential beyond traditional biotechnology. A pioneering development featured in PNAS introduces the DNA-DISK platform, which integrates enzymatic single-nucleotide DNA synthesis and sequencing with digital microfluidics. This end-to-end, fully automated system encodes digital data into DNA strands using terminal deoxynucleotidyl transferase (TdT), offering a streamlined and scalable alternative to conventional synthesis and sequencing workflows. By eliminating harsh chemicals and enabling synthesis in aqueous environments, this platform aligns with the global shift toward safer, faster, and more sustainable production methods.

The innovation lies in its ability to automate the entire DNA data storage cycle-from writing to reading-within a compact and digitally controlled setup. The system's enzymatic precision allows for single-base additions, essential for encoding data accurately. This development reinforces enzymatic DNA synthesis as a flexible tool that can support decentralized synthesis models, especially in domains that require high-throughput and precision, such as bioinformatics and digital archiving. Companies in the sector, including DNA Script, Molecular Assemblies, and Ansa Biotechnologies, are already pursuing similar technological directions to meet demand for advanced, application-specific synthesis platforms.

This advancement reflects the evolving scope and commercial potential of enzymatic synthesis technologies. As demand grows for miniaturized, sustainable, and automated systems capable of operating beyond genomic applications, innovations such as DNA-DISK signal a significant market opportunity. DNA-based data storage-valued for its density, longevity, and eco-efficiency-is gaining traction as a frontier technology. The ability to synthesize and process DNA sequences autonomously opens doors to new collaborations and market expansion, positioning enzymatic synthesis as a critical enabler of next-generation molecular solutions across synthetic biology, data science, and decentralized biomanufacturing.

Scalable DNA Innovation Reshaping the Future of Synthetic Biology

Enzymatic DNA synthesis (EDS) is rapidly emerging as a transformative alternative to traditional chemical methods, addressing long-standing limitations in length, fidelity, and environmental sustainability. While phosphoramidite chemistry has dominated DNA synthesis for decades, it struggles to efficiently produce sequences beyond 300 bases due to cumulative cycle inefficiencies and high error rates. In contrast, EDS uses terminal deoxynucleotidyl transferase (TdT) to add nucleotides under mild, aqueous conditions, enabling high-purity synthesis of longer DNA fragments. This leap in technical capability is crucial for supporting advanced applications in genomics, gene editing, synthetic biology, and mRNA-based drug development.

From a commercial standpoint, the shift toward EDS is unlocking new growth avenues across the life sciences sector. The ability to produce long, accurate, and sequence-diverse DNA constructs quickly and sustainably offers a competitive edge in high-throughput R&D and decentralized biomanufacturing. Companies pioneering this shift are gaining strategic traction by offering benchtop instruments, on-demand synthesis services, and early-access programs tailored for use in therapeutics, vaccine development, and next-generation bioengineering. As industries prioritize faster iteration cycles, reduced reliance on outsourcing, and greener technologies, enzymatic DNA synthesis is redefining the competitive landscape, positioning itself as a cornerstone of the evolving synthetic biology ecosystem.

Global Enzymatic DNA Synthesis Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global enzymatic DNA synthesis market report based on services, application, end use, and region.

  • Services Outlook (Revenue, USD Million, 2021 - 2033)
  • Oligonucleotide Synthesis
  • Gene Synthesis
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Synthetic Biology
  • Genetic Engineering
  • Vaccine Development
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Biopharmaceutical Companies
  • Academic & Research Institutes
  • Contract Research Organizations
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Chile
  • MEA
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Services
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Enzymatic DNA Synthesis Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing biopharmaceutical industry
      • 3.2.1.2. Rising demand for precision medicine
      • 3.2.1.3. Increasing research in synthetic biology
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High costs of enzymatic DNA synthesis
  • 3.3. Enzymatic DNA Synthesis Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Enzymatic DNA Synthesis Market: Services Estimates & Trend Analysis

  • 4.1. Services Segment Dashboard
  • 4.2. Global Enzymatic DNA Synthesis Market Services Movement Analysis
  • 4.3. Global Enzymatic DNA Synthesis Market Size & Trend Analysis, by Services, 2021 to 2033 (USD Million)
  • 4.4. Oligonucleotide Synthesis
    • 4.4.1. Oligonucleotide synthesis market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Gene Synthesis
    • 4.5.1. Gene synthesis market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Enzymatic DNA Synthesis Market: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Global Enzymatic DNA Synthesis Market Application Movement Analysis
  • 5.3. Global Enzymatic DNA Synthesis Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Synthetic Biology
    • 5.4.1. Synthetic biology market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Vaccine Development
    • 5.5.1. Vaccine development market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Genetic Engineering
    • 5.6.1. Genetic engineering market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Enzymatic DNA Synthesis Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Global Enzymatic DNA Synthesis Market End Use Movement Analysis
  • 6.3. Global Enzymatic DNA Synthesis Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Biopharmaceutical Companies
    • 6.4.1. Biopharmaceutical companies market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Academic & research institutes market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Contract Research Organizations
    • 6.6.1. Contract research organizations market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Enzymatic DNA Synthesis Market: Regional Estimates & Trend Analysis by Services, Application, and End Use

  • 7.1. Regional Market Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033
  • 7.3. North America
    • 7.3.1. North America market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.9. Denmark
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Regulatory framework
      • 7.4.9.3. Competitive scenario
      • 7.4.9.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. Chile
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Chile market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Telesis Bio Inc.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Twist Bioscience Corporation
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. GenScript Biotech Corp.
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Evonetix
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Ansa Biotechnologies, Inc.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Camena Bio
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Molecular Assemblies
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. DNA Script
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Touchlight
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Kern Systems
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives